---
figid: PMC9312025__antioxidants-11-01297-g003
figtitle: Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
organisms:
- Homo sapiens
- Rattus norvegicus
organisms_ner:
- NA
pmcid: PMC9312025
filename: antioxidants-11-01297-g003.jpg
figlink: /pmc/articles/PMC9312025/figure/antioxidants-11-01297-f003/
number: F3
caption: Illustration of the pentose phosphate pathway (PPP). Allopurinol-mediated
  inhibition of PPP reduces ribose-5-phosphate availability for purine synthesis,
  which likely contributes to the urate-lowering effect of the drug. Allopurinol,
  additionally, inhibits the oxidative branch of the PPP and may result in reduced
  availability NADPH.
papertitle: Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in
  CKD.
reftext: Mingyao Sun, et al. Antioxidants (Basel). 2022 Jul;11(7):1297.
year: '2022'
doi: 10.3390/antiox11071297
journal_title: Antioxidants
journal_nlm_ta: Antioxidants (Basel)
publisher_name: MDPI
keywords: xanthine oxidase | urate | chronic kidney disease
automl_pathway: 0.9271811
figid_alias: PMC9312025__F3
figtype: Figure
redirect_from: /figures/PMC9312025__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9312025__antioxidants-11-01297-g003.html
  '@type': Dataset
  description: Illustration of the pentose phosphate pathway (PPP). Allopurinol-mediated
    inhibition of PPP reduces ribose-5-phosphate availability for purine synthesis,
    which likely contributes to the urate-lowering effect of the drug. Allopurinol,
    additionally, inhibits the oxidative branch of the PPP and may result in reduced
    availability NADPH.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - 2NADP
  - Glucose-6-phosphate
  - 2NADPH
  - Glutathione
  - Fatty acids
  - Ribulose-5-phosphate
  - Ribose-5-phosphate
  - Nucleotide
---
